Smiths Medical Announces Launch of Portex® EchoGlo® Peripheral Nerve Block Portfolio

PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC

IDS’s portfolio and expertise will seamlessly integrate within EUROIMMUN, a PerkinElmer company since 2017.

Precision Spine Reaches Milestone with the Reform® Modular Pedicle Screw System

The Reform® Modular Pedicle Screw System provides surgeons with increased flexibility, versatility, and visibility to meet the varying requirements of degenerative and trauma procedures.

December 14, 2020

Smiths Medical has announced the launch of its EchoGlo® peripheral nerve block portfolio. This addition to the Portex® portfolio of pain management products offers customers a complete solution for regional anesthesia from pump to patient.

The Portex® EchoGlo® needle has been engineered for echogenic brightness under ultrasound even at extreme angles, which can enhance visualization and accuracy in delivering medication. This proprietary technology helps clinicians to confidently place local anesthetic, which may reduce post-operative dependency on opioids1.

“Smiths Medical is proud to offer EchoGlo® nerve block needles as part of our patient to pump solution. Combining the echogenic brightness of EchoGlo® products with our CADD® pump portfolio provides a full solution for our clinicians and patients,” said Jaimie Mattson, Senior Director, Global Product Management at Smiths Medical.

Smiths Medical notes the launch of the full EchoGlo® portfolio enables Smiths Medical to offer clinicians more solutions to treat their patients safely and effectively.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles